BioNTech SE (BNTX)
USD 104.94
(2.45%)
USD 104.94
(2.45%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.52 Billion EUR | 1603.46% |
| 2022 | 135.9 Million EUR | -32.08% |
| 2021 | 200.1 Million EUR | 243.32% |
| 2020 | -139.62 Million EUR | -401.69% |
| 2019 | 46.28 Million EUR | 87.38% |
| 2018 | 24.69 Million EUR | -11.98% |
| 2017 | 28.06 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 772.28 Million EUR | 62.83% |
| 2024 Q1 | 635.7 Million EUR | -9.43% |
| 2023 Q4 | 701.9 Million EUR | 356.67% |
| 2023 FY | 2.31 Billion EUR | 1603.46% |
| 2023 Q3 | 153.7 Million EUR | -21.06% |
| 2023 Q2 | 194.7 Million EUR | 65.0% |
| 2023 Q1 | 118 Million EUR | -59.6% |
| 2022 FY | 135.9 Million EUR | -32.08% |
| 2022 Q3 | 145.5 Million EUR | 31.91% |
| 2022 Q2 | 110.3 Million EUR | 10.85% |
| 2022 Q1 | 99.5 Million EUR | -5.69% |
| 2022 Q4 | 292.1 Million EUR | 100.76% |
| 2021 Q2 | 59.6 Million EUR | -69.25% |
| 2021 FY | 200.1 Million EUR | 243.32% |
| 2021 Q1 | 193.8 Million EUR | 202.14% |
| 2021 Q4 | 105.5 Million EUR | 83.8% |
| 2021 Q3 | 57.4 Million EUR | -3.69% |
| 2020 FY | -139.62 Million EUR | -401.69% |
| 2020 Q4 | -189.74 Million EUR | -1083.42% |
| 2020 Q3 | 19.29 Million EUR | -11.71% |
| 2020 Q1 | 15.97 Million EUR | 44.34% |
| 2020 Q2 | 21.85 Million EUR | 36.79% |
| 2019 Q3 | 10.91 Million EUR | -26.09% |
| 2019 Q2 | 14.76 Million EUR | 54.68% |
| 2019 Q1 | 9.54 Million EUR | -3.64% |
| 2019 FY | 46.28 Million EUR | 87.38% |
| 2019 Q4 | 11.06 Million EUR | 1.45% |
| 2018 Q1 | 30.27 Million EUR | 0.0% |
| 2018 Q4 | 9.9 Million EUR | 53.38% |
| 2018 FY | 24.69 Million EUR | -11.98% |
| 2018 Q3 | 6.45 Million EUR | -78.67% |
| 2018 Q2 | 30.27 Million EUR | 0.0% |
| 2017 FY | 28.06 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Absci Corporation | 73.66 Million USD | -3332.791% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -685.932% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | -40.484% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -25346.673% |
| Apollomics, Inc. | 54.14 Million USD | -4570.853% |
| 180 Life Sciences Corp. | 13.47 Million USD | -18663.124% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -7959.407% |
| Bicycle Therapeutics plc | 216.92 Million USD | -1065.765% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -2885.032% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -1371.071% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -5279.739% |
| Chimerix, Inc. | 93.38 Million USD | -2607.814% |
| CRISPR Therapeutics AG | 463.49 Million USD | -445.595% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -7397.628% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -2071.52% |
| Fortress Biotech, Inc. | 200.19 Million USD | -1163.168% |
| Fortress Biotech, Inc. | 200.19 Million USD | -1163.168% |
| Gritstone bio, Inc. | 148.37 Million USD | -1604.342% |
| Allakos Inc. | 196.05 Million USD | -1189.836% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -4514.935% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -1675.057% |
| Cytokinetics, Incorporated | 173.61 Million USD | -1356.581% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -9669.364% |
| Innoviva, Inc. | 132.15 Million USD | -1813.525% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -32774.681% |
| NLS Pharmaceutics AG | 11.8 Million USD | -21317.689% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -1890.21% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -19612122.739% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -2365.727% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -2745.633% |
| ImmuCell Corporation | 9.61 Million USD | -26194.113% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -1502.393% |
| Incyte Corporation | 1.19 Billion USD | -112.416% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -1807.735% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -37482.129% |
| Mustang Bio, Inc. | 48.5 Million USD | -5113.913% |
| MiMedx Group, Inc. | 229.72 Million USD | -1000.785% |
| MEI Pharma, Inc. | 34.78 Million USD | -7169.8% |
| MacroGenics, Inc. | 217.21 Million USD | -1064.192% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -28534.727% |
| Mereo BioPharma Group plc | 35.84 Million USD | -6955.41% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -14033.287% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -1475.184% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -1371.516% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -10852.594% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -15818.419% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -24487.263% |
| NextCure, Inc. | 67.63 Million USD | -3638.782% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -4576.036% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -8441.512% |
| Onconetix, Inc. | 34.9 Million USD | -7144.303% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -19739.95% |
| Opthea Limited | 191.96 Million USD | -1217.307% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -4137.751% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -91803.394% |
| PDS Biotechnology Corporation | 43.04 Million USD | -5774.75% |
| Precigen, Inc. | 84.18 Million USD | -2904.003% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -3384.828% |
| Prime Medicine, Inc. | 186.63 Million USD | -1254.915% |
| PureTech Health plc | 144.59 Million USD | -1648.861% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -873.893% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 10.177% |
| Replimune Group, Inc. | 234.77 Million USD | -977.126% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -29112.177% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -1841.303% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -12922.622% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -407.012% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -10303.755% |
| Sesen Bio, Inc. | 78.38 Million USD | -3126.292% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -1005.825% |
| Solid Biosciences Inc. | 104.31 Million USD | -2324.196% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -999.698% |
| SciSparc Ltd. | 9.01 Million USD | -27963.478% |
| Sutro Biopharma, Inc. | 243 Million USD | -940.62% |
| TG Therapeutics, Inc. | 198.47 Million USD | -1174.115% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -1982.911% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -33793.58% |
| Travere Therapeutics, Inc. | 472 Million USD | -435.76% |
| UroGen Pharma Ltd. | 138.88 Million USD | -1720.748% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -3482.174% |
| XOMA Corporation | 46.46 Million USD | -5342.61% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -901.299% |
| AbCellera Biologics Inc. | 275.23 Million USD | -818.789% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -4355.329% |
| Cassava Sciences, Inc. | 105.95 Million USD | -2286.629% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -18080.196% |
| Precision BioSciences, Inc. | 92.46 Million USD | -2634.932% |
| Dyadic International, Inc. | 9.15 Million USD | -27529.018% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -30297.884% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -11263.861% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -8419.642% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -1827.542% |
| IGM Biosciences, Inc. | 265.59 Million USD | -852.141% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -2251.891% |
| Acelyrin, Inc. | 422.06 Million USD | -499.151% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -13996.66% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -2898.945% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -37464.187% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -932.146% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -8118.127% |
| Senti Biosciences, Inc. | 94.7 Million USD | -2570.186% |
| Mesoblast Limited | 5.9 Million USD | -42746.493% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -935.876% |
| ChromaDex Corporation | 56.37 Million USD | -4385.358% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -7487.141% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -1157.39% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -31345.282% |
| Seer, Inc. | 110.49 Million USD | -2188.714% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -1401.342% |
| Novavax, Inc. | 779.12 Million USD | -224.569% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -16017.49% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -895.418% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -4739.716% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -923.234% |
| Celcuity Inc. | 66.23 Million USD | -3718.19% |
| ContextLogic Inc. | 387 Million USD | -553.437% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -1406.79% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -7622.47% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 22.325% |
| Amarin Corporation plc | 272.35 Million USD | -828.487% |
| AnaptysBio, Inc. | 181.56 Million USD | -1292.756% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -8656.839% |
| Aptorum Group Limited | 10.56 Thousand USD | -23933271.191% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -2180.931% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -467.33% |
| Ardelyx, Inc. | 169.93 Million USD | -1388.081% |
| Celularity Inc. | 215.05 Million USD | -1075.869% |
| Omeros Corporation | 94.75 Million USD | -2568.89% |
| Humacyte, Inc. | 23.49 Million USD | -10662.225% |
| Immunocore Holdings plc | 308.04 Million USD | -720.932% |
| IO Biotech, Inc. | 91.44 Million USD | -2665.439% |
| GT Biopharma, Inc. | 13.57 Million USD | -18526.989% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -3287.088% |
| Summit Therapeutics Inc. | 87.68 Million USD | -2783.927% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -8481.221% |
| Pulmatrix, Inc. | 22.03 Million USD | -11374.725% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -358.476% |
| Evogene Ltd. | 27.79 Million USD | -8999.676% |
| CorMedix Inc. | 48.95 Million USD | -5065.266% |
| BioLineRx Ltd. | 50.8 Million USD | -4877.757% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -7319.099% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -7623.885% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | -92.768% |
| scPharmaceuticals Inc. | 65.17 Million USD | -3779.837% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -2128.626% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -586.033% |
| NLS Pharmaceutics AG | 11.8 Million USD | -21317.689% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -10303.755% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -1362.833% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -6660.051% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -9736.627% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -1946.733% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -2944.803% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -4659.97% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -29816.941% |
| Daré Bioscience, Inc. | 33.6 Million USD | -7424.085% |
| bluebird bio, Inc. | 240.23 Million USD | -952.649% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | -44.811% |
| DBV Technologies S.A. | 92.16 Million USD | -2643.924% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -931.498% |
| Galecto, Inc. | 35.62 Million USD | -6997.987% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -6722.793% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -3973.322% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -1050.343% |
| GlycoMimetics, Inc. | 39.28 Million USD | -6337.014% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -755.133% |
| ADMA Biologics, Inc. | 66.58 Million USD | -3697.795% |
| Clene Inc. | 41.07 Million USD | -6056.843% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -618.311% |
| Aptose Biosciences Inc. | 52.35 Million USD | -4730.01% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -17448.469% |
| Soligenix, Inc. | 7.79 Million USD | -32340.264% |
| Century Therapeutics, Inc. | 56.07 Million USD | -4409.996% |
| Kura Oncology, Inc. | 165.8 Million USD | -1425.174% |
| Surrozen, Inc. | 18.55 Million USD | -13532.345% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -2108.424% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -101800.397% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -2248.047% |
| Autolus Therapeutics plc | 196.72 Million USD | -1185.443% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -2887.113% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -12946.484% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -1579.864% |
| GRI Bio, Inc. | 11.33 Million USD | -22219.506% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -35740.521% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -3019.587% |
| INmune Bio, Inc. | 29.89 Million USD | -8358.657% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -1365.512% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -6172.71% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -15725.414% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -30611.903% |
| Jaguar Health, Inc. | 42.01 Million USD | -5918.803% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -15964.489% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -3972.273% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -7629.788% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -817.252% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -738.876% |
| Verastem, Inc. | 92.08 Million USD | -2646.188% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -1261.583% |
| Histogen Inc. | 14.27 Million USD | -17618.61% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -15657.587% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -235.347% |
| Surrozen, Inc. | 18.55 Million USD | -13532.345% |
| Organovo Holdings, Inc. | 14.91 Million USD | -16854.744% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -49579.425% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -33030.512% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -1319.59% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -5119.622% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -16356.498% |
| Kronos Bio, Inc. | 128.11 Million USD | -1873.805% |
| Turnstone Biologics Corp. | 78.33 Million USD | -3128.063% |
| Synaptogenix, Inc. | 8.31 Million USD | -30316.7% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -17237.173% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -1813.221% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -899.305% |
| Exelixis, Inc. | 1.58 Billion USD | -59.367% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -989.765% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -195.696% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -3572.325% |
| ESSA Pharma Inc. | 32.13 Million USD | -7769.521% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -15357.007% |
| Avid Bioservices, Inc. | 25.99 Million USD | -9627.65% |
| Insmed Incorporated | 949.26 Million USD | -166.397% |
| MediWound Ltd. | 18.86 Million USD | -13302.586% |
| OmniAb, Inc. | 83.89 Million USD | -2914.244% |
| Alector, Inc. | 248.8 Million USD | -916.391% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -979.263% |
| Zai Lab Limited | 547.47 Million USD | -361.902% |
| AlloVir, Inc. | 180.93 Million USD | -1297.644% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -534.335% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -2182.723% |
| Aura Biosciences, Inc. | 84.99 Million USD | -2875.374% |
| Immunic, Inc. | 99.22 Million USD | -2448.603% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -1490.32% |
| Veracyte, Inc. | 357.93 Million USD | -606.501% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 71.951% |
| FibroGen, Inc. | 398.11 Million USD | -535.197% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -17695.918% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -874.771% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -36613.407% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -35388.284% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -9673.896% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -698.88% |
| Fortrea Holdings Inc. | 457.3 Million USD | -452.985% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -4558.978% |
| XBiotech Inc. | 37.51 Million USD | -6641.669% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -3572.325% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -1393.883% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -6577.758% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -12146.598% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -1680.08% |
| Agenus Inc. | 78.18 Million USD | -3134.463% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -2452.41% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -2184.042% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | -163.898% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -8666.857% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -487.219% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -11235.685% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -1482.607% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -45620.914% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -9832.833% |
| Lantern Pharma Inc. | 17.87 Million USD | -14045.099% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -5780.93% |
| Ainos, Inc. | 12.95 Million USD | -19423.398% |
| Pluri Inc. | 22.48 Million USD | -11149.11% |
| Prothena Corporation plc | 282.4 Million USD | -795.448% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -1164.261% |
| Rallybio Corporation | 78.93 Million USD | -3103.77% |
| Kodiak Sciences Inc. | 277.32 Million USD | -811.867% |
| Cue Biopharma, Inc. | 19.54 Million USD | -12840.334% |
| MeiraGTx Holdings plc | 151.07 Million USD | -1573.837% |
| Annexon, Inc. | 143.72 Million USD | -1659.496% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -10938.457% |
| Moderna, Inc. | 6.39 Billion USD | 60.45% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -74495.87% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -2811.184% |
| Blueprint Medicines Corporation | 722.86 Million USD | -249.832% |
| Immix Biopharma, Inc. | 16.14 Million USD | -15566.825% |
| CalciMedica, Inc. | 21.81 Million USD | -11490.961% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -1664.554% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -1376.284% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -1294.808% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -757.395% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -7213.955% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -3385.548% |
| Nutriband Inc. | 5.73 Million USD | -44001.61% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -5698.271% |
| Vor Biopharma Inc. | 126.03 Million USD | -1906.411% |
| Roivant Sciences Ltd. | 1.18 Billion USD | -112.651% |
| Alkermes plc | 996.24 Million USD | -153.833% |
| ProKidney Corp. | 151.52 Million USD | -1568.933% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -3309.235% |
| Arcellx, Inc. | 200.19 Million USD | -1163.143% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -311.704% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -1578.036% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -6542.152% |
| Atai Life Sciences N.V. | 125.78 Million USD | -1910.415% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -2997.528% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -3006.29% |
| MediciNova, Inc. | 10.9 Million USD | -23099.436% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -1863.049% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -34734.24% |
| GeoVax Labs, Inc. | 6.02 Million USD | -41891.487% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -430.859% |
| Biomea Fusion, Inc. | 126.13 Million USD | -1904.836% |
| RenovoRx, Inc. | 11.39 Million USD | -22090.242% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -1223.362% |
| Geron Corporation | 70.44 Million USD | -3489.955% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -9068.298% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -1792.956% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -944.26% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -865.014% |
| Royalty Pharma plc | 862.4 Million USD | -193.227% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -1115.804% |
| Imunon, Inc. | 20.31 Million USD | -12350.749% |
| BioAtla, Inc. | 129.68 Million USD | -1849.926% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -2877.932% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -5955.846% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -1116.869% |
| Structure Therapeutics Inc. | 102.77 Million USD | -2360.521% |
| 89bio, Inc. | 151.2 Million USD | -1572.443% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -2174.694% |
| aTyr Pharma, Inc. | 12.97 Million USD | -19383.781% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -2339.608% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -892.605% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -30645.984% |
| Akari Therapeutics, Plc | 16.8 Million USD | -14947.007% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -111106.392% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -744.854% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -1362.842% |
| Liquidia Corporation | 87.98 Million USD | -2774.159% |
| Entera Bio Ltd. | 8.86 Million USD | -28441.761% |
| GH Research PLC | 41.22 Million USD | -6034.588% |
| Vericel Corporation | 142.04 Million USD | -1680.344% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -11117.175% |
| Xencor, Inc. | 306.97 Million USD | -723.775% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -51156.626% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -15725.414% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -12241.698% |
| Vaxcyte, Inc. | 468.04 Million USD | -440.295% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -5333.372% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -1218.484% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -37482.129% |
| Portage Biotech Inc. | 18.19 Million USD | -13795.269% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -34734.24% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -2309.276% |
| OncoCyte Corporation | 25.63 Million USD | -9763.869% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -41385.614% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -21971.978% |
| Purple Biotech Ltd. | -22.46 Million USD | 11355.619% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -8573.046% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -8094.692% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -901.572% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -15244.66% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -8434.305% |
| United Therapeutics Corporation | 885.1 Million USD | -185.708% |
| HilleVax, Inc. | 133.34 Million USD | -1796.434% |
| Silo Pharma, Inc. | 3.92 Million USD | -64379.675% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -64049.396% |
| Pharming Group N.V. | 225.49 Million USD | -1021.464% |
| Tharimmune, Inc. | 9.45 Million USD | -26645.015% |
| Genprex, Inc. | 31.06 Million USD | -8041.513% |
| Apogee Therapeutics, Inc. | 93 Million USD | -2619.052% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -1248.506% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -2976.549% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -330462.092% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -46326.246% |
| OKYO Pharma Limited | 8243.57 USD | -30675929.924% |
| Savara Inc. | 15.74 Million USD | -15960.972% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -14385.88% |
| Curis, Inc. | 58.35 Million USD | -4233.476% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -49557.456% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -9258.301% |
| BeiGene, Ltd. | 3.28 Billion USD | 23.057% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -1545.797% |
| Erasca, Inc. | 141.52 Million USD | -1686.822% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -55760.714% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -55760.714% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -5834.896% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -17502.673% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -3691.248% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -5724.849% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -1115.01% |
| Adicet Bio, Inc. | 152.03 Million USD | -1563.268% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -491.323% |
| Aditxt, Inc. | 25.95 Million USD | -9644.607% |
| Adagene Inc. | 41.83 Million USD | -5945.226% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -34493.243% |
| Quantum-Si incorporated | 111.65 Million USD | -2164.753% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -17246.963% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -6959.349% |
| Compugen Ltd. | 43.97 Million USD | -5651.063% |
| Generation Bio Co. | 144.46 Million USD | -1650.434% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -2945.646% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -2824.821% |
| Invivyd, Inc. | 205.75 Million USD | -1129.035% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -3404.483% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -26863.789% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -3260.353% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -24482.483% |
| 2seventy bio, Inc. | 289.88 Million USD | -772.34% |
| Instil Bio, Inc. | 85.78 Million USD | -2847.835% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -19644.086% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -222784.239% |
| GeoVax Labs, Inc. | 6.02 Million USD | -41891.487% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -6784.457% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -2338.526% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -1385.101% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -229.391% |
| Evaxion Biotech A/S | 22.27 Million USD | -11255.186% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -1765.667% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -976.626% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -3063.175% |
| Cingulate Inc. | 22.75 Million USD | -11011.116% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 33853.337% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -5561.45% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -3973.847% |
| Clearmind Medicine Inc. | 8.74 Million USD | -28829.17% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -2907.898% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -86119.329% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -2408.058% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -564.606% |
| ImmunityBio, Inc. | 362.87 Million USD | -596.885% |
| Korro Bio, Inc. | 84.53 Million USD | -2891.459% |
| Kineta, Inc. | 21.15 Million USD | -11853.11% |
| BioVie Inc. | 31.95 Million USD | -7814.815% |
| Codexis, Inc. | 66.51 Million USD | -3701.678% |
| Celularity Inc. | 215.05 Million USD | -1075.869% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -15436.987% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -1015.872% |
| Virax Biolabs Group Limited | 6.54 Million USD | -38524.953% |
| Cibus, Inc. | 320.3 Million USD | -689.498% |
| IN8bio, Inc. | 30.33 Million USD | -8235.696% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -1881.958% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -395025.0% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -224.377% |
| Eyenovia, Inc. | 25.4 Million USD | -9853.38% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -1702.231% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -45365.66% |
| Elevation Oncology, Inc. | 45.44 Million USD | -5464.529% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -3095.633% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -5409.368% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -1068.517% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -25297.208% |
| Moolec Science SA | 52.75 Million USD | -4693.878% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -4036.216% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -5333.606% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -2588.154% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -5116.925% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -27010.166% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -11075.272% |
| Humacyte, Inc. | 23.49 Million USD | -10662.225% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -3055.793% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -17292.022% |
| Genelux Corporation | 24.33 Million USD | -10291.617% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -7354.529% |
| Notable Labs, Ltd. | 14.77 Million USD | -17021.192% |
| Immunovant, Inc. | 282.7 Million USD | -794.489% |
| Quantum-Si incorporated | 111.65 Million USD | -2164.753% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -11790.723% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -2378.924% |
| Acasti Pharma Inc. | 11.3 Million USD | -22276.781% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -10932.627% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -6010.574% |
| PepGen Inc. | 84.76 Million USD | -2883.272% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -10944.242% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -7627.299% |
| Immuneering Corporation | 58.41 Million USD | -4229.182% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -49579.425% |
| Belite Bio, Inc | 31.66 Million USD | -7885.348% |
| XOMA Corporation | 46.46 Million USD | -5342.61% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -3643.597% |
| Bionomics Limited | 17.89 Billion USD | 85.867% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 7187.444% |
| uniQure N.V. | 285.08 Million USD | -787.031% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -34493.243% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -1202.116% |
| Forte Biosciences, Inc. | 32.47 Million USD | -7686.434% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -30335.366% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -8502.824% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -45365.66% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -17695.918% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -28348.644% |
| Altimmune, Inc. | 30.55 Million USD | -8175.952% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -3476.652% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 7187.444% |
| Peak Bio, Inc. | 1249.13 USD | -202444801.652% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -3311.765% |
| Benitec Biopharma Inc. | 22.38 Million USD | -11198.365% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -939.85% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -8759.615% |
| Zura Bio Limited | 62.63 Million USD | -3937.166% |
| PolyPid Ltd. | 21.04 Million USD | -11916.156% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -8759.615% |
| argenx SE | 1.53 Billion USD | -64.901% |
| Immunome, Inc. | 122.82 Million USD | -1958.948% |
| Verona Pharma plc | 67.15 Million USD | -3665.826% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -9669.364% |
| Shattuck Labs, Inc. | 93.61 Million USD | -2601.305% |
| CervoMed Inc. | 14.95 Million USD | -16806.267% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -29497.378% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -4858.431% |
| Moolec Science SA | 52.75 Million USD | -4693.878% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -15274.102% |
| Design Therapeutics, Inc. | 78.19 Million USD | -3134.173% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -2805.298% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -19993.762% |
| Achilles Therapeutics plc | 75.25 Million USD | -3260.308% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -86119.329% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -4443.87% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -4870.223% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -3725.776% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -4572.312% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -5468.94% |
| Beam Therapeutics Inc. | 554.19 Million USD | -356.302% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -917.671% |
| AEON Biopharma, Inc. | 48.42 Million USD | -5121.665% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -2605.235% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -2927.452% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -19990.736% |
| NeurAxis, Inc. | 8.82 Million USD | -28567.305% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -460.718% |
| Lumos Pharma, Inc. | 38.66 Million USD | -6440.282% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -9441.762% |
| Palisade Bio, Inc. | 13.32 Million USD | -18884.985% |
| Nutriband Inc. | 5.73 Million USD | -44001.61% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -2777.233% |
| Neurogene Inc. | 55.58 Million USD | -4449.593% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -29823.086% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -2514.828% |
| Athira Pharma, Inc. | 125.46 Million USD | -1915.526% |
| HCW Biologics Inc. | 21.02 Million USD | -11926.145% |
| XOMA Corporation | 46.46 Million USD | -5342.61% |
| Nektar Therapeutics | 190.9 Million USD | -1224.652% |
| Arvinas, Inc. | 480 Million USD | -426.833% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -111106.392% |
| Merus N.V. | 200.49 Million USD | -1161.285% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -2346.713% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -7204.448% |
| Rezolute, Inc. | 70.38 Million USD | -3492.709% |
| Clene Inc. | 41.07 Million USD | -6056.843% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -15339.778% |
| BeyondSpring Inc. | 24.86 Million USD | -10070.119% |
| Synlogic, Inc. | 58.53 Million USD | -4220.372% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -14033.691% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -56195.637% |
| Peak Bio, Inc. | 1249.13 USD | -202444801.652% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -4083.569% |
| Krystal Biotech, Inc. | 160.42 Million USD | -1476.303% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -834.409% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -626.587% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -117151.362% |
| MannKind Corporation | 125.59 Million USD | -1913.424% |
| Ikena Oncology, Inc. | 84.57 Million USD | -2889.938% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -26113.331% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -2722.29% |
| Gossamer Bio, Inc. | 183.75 Million USD | -1276.15% |
| CohBar, Inc. | 12.38 Million USD | -20312.814% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -4885.411% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -9068.298% |
| Legend Biotech Corporation | 583.14 Million USD | -333.649% |
| Mural Oncology plc | 192.07 Million USD | -1216.596% |
| Disc Medicine, Inc. | 91.12 Million USD | -2675.089% |
| Champions Oncology, Inc. | 28.11 Million USD | -8896.087% |
| REGENXBIO Inc. | 321.15 Million USD | -687.403% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -47068.245% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -4435.476% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -6390.653% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -2111.321% |
| Vaxart, Inc. | 90.72 Million USD | -2687.294% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -29580.723% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -5809.228% |
| Cellectis S.A. | 97.32 Million USD | -2498.438% |
| Longeveron Inc. | 21.25 Million USD | -11800.235% |
| Repare Therapeutics Inc. | 167.35 Million USD | -1411.021% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | -85.83% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -3242.984% |
| Revolution Medicines, Inc. | 498.76 Million USD | -407.012% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -37915.634% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -5653.288% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -3290.267% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -3531.507% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -22764.376% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 47.041% |
| Denali Therapeutics Inc. | 527.23 Million USD | -379.639% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -29112.177% |
| Veru Inc. | 101.34 Million USD | -2395.162% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -10703.606% |
| Cingulate Inc. | 22.75 Million USD | -11011.116% |
| Passage Bio, Inc. | 108.38 Million USD | -2233.078% |
| Context Therapeutics Inc. | 25.07 Million USD | -9985.904% |
| Exicure, Inc. | 14.07 Million USD | -17865.331% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -1127.192% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -5740.05% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -27454.975% |
| Nuvalent, Inc. | 149.49 Million USD | -1591.596% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -31247.846% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -2339.749% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -11689.827% |
| OmniAb, Inc. | 83.89 Million USD | -2914.244% |
| Anew Medical, Inc. | 1.3 Million USD | -194297.317% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -7618.227% |
| Lipocine Inc. | 15.08 Million USD | -16669.076% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -3590.978% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -3220.727% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -6172.71% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -2101.963% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -11197.355% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -280.76% |
| Ocugen, Inc. | 71.56 Million USD | -3433.472% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -2594.053% |
| Q32 Bio Inc. | 92.68 Million USD | -2628.528% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -11842.949% |
| Alumis Inc. Common Stock | 158.17 Million USD | -1498.746% |
| Equillium, Inc. | 50.6 Million USD | -4897.036% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -3952.174% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -18085.538% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -13304.641% |
| Dominari Holdings Inc. | 23.83 Million USD | -10509.608% |
| Edesa Biotech, Inc. | 9.22 Million USD | -27319.13% |
| vTv Therapeutics Inc. | 11.9 Million USD | -21137.927% |
| Bio-Techne Corporation | 563.03 Million USD | -349.134% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -518.582% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -840.928% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -1811.746% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -17447.707% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -1444.815% |
| Nkarta, Inc. | 131.65 Million USD | -1820.851% |
| BioCardia, Inc. | 12.12 Million USD | -20762.965% |
| Iterum Therapeutics plc | 47.46 Million USD | -5227.378% |